Stocks›Healthcare›VTRS

VTRS Viatris Inc.

NasdaqResearch view

Viatris Inc. operates in the Pharmaceutical Preparations industry.

$18.66+2.39%

Oct 16 close · 1D EOD · Databento

HealthcarePharmaceutical PreparationsLarge-capSEC EDGAR FY 2025-12-31

On the WireNo stories on VTRS yet. Follow the company and the next one lands in Following.

What happened

Daily closes · dots are Wire stories

What’s next

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 6, 2025 and Nov 7, 2024, during the session.

Last report

Aug 6, 2026−7.71%

during the session

Last 4, next close

median 6.83% either way

up 1 of 4

Every report since 2022 →Earnings calendar →

DateEventSourceNext close

Aug 6Earnings release, during the session · 8-KSEC EDGARSEC EDGAR ↗−7.71%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

22 big days in a year, and what we hold on each

A big day is a close more than 3.12% from the one before, three times VTRS’s median day (1.04%). On 2 of the 22, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±3.12%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayVTRSWhat we hold that dayGroup (median of 4) · each

1 Nov 6, 2025−5.95%
Resultsgroup +1.2%, did not move with it
1Nov 6, 2025−5.95%
ResultsFirst close after the Nov 6 results filing
+1.2% did not move with itJNJ +0.5 · ABBV +1.1 · LLY +1.3 · MRK +1.6
2 Nov 11, 2025+10.13%
Before our storiesgroup +2.9%, did not move with it
2Nov 11, 2025+10.13%
Before our stories
+2.9% did not move with itMRK +4.8 · ABBV +3.0 · JNJ +2.9 · LLY +2.3
3 Dec 10, 2025+3.66%
Before our storiesgroup +1.1%, did not move with it
3Dec 10, 2025+3.66%
Before our stories
+1.1% did not move with itJNJ +3.3 · LLY +1.2 · ABBV +1.0 · MRK +0.8
4 Jan 13, 2026+5.44%
Before our storiesgroup −0.0%, did not move with it
4Jan 13, 2026+5.44%
Before our stories
−0.0% did not move with itJNJ +1.9 · ABBV +0.3 · LLY −0.3 · MRK −0.8
5 Feb 2, 2026+4.51%
Before our storiesgroup +1.4%, did not move with it
5Feb 2, 2026+4.51%
Before our stories
+1.4% did not move with itMRK +2.8 · JNJ +1.5 · ABBV +1.2 · LLY +0.7
6 Feb 4, 2026+4.97%
Before our storiesgroup +1.4%, did not move with it
6Feb 4, 2026+4.97%
Before our stories
+1.4% did not move with itLLY +10.3 · MRK +2.1 · JNJ +0.6 · ABBV −3.8
7 Feb 9, 2026+6.72%
Before our storiesgroup −0.9%, did not move with it
7Feb 9, 2026+6.72%
Before our stories
−0.9% did not move with itABBV −0.1 · JNJ −0.6 · LLY −1.3 · MRK −3.5
8 Feb 26, 2026−5.16%
Resultsgroup −0.8%, did not move with it
8Feb 26, 2026−5.16%
ResultsFirst close after the Feb 26 results filing
−0.8% did not move with itMRK −2.6 · ABBV −1.0 · JNJ −0.7 · LLY −0.7
9 Mar 2, 2026+5.16%
Before our storiesgroup −0.9%, did not move with it
9Mar 2, 2026+5.16%
Before our stories
−0.9% did not move with itABBV +0.9 · JNJ +0.1 · MRK −1.9 · LLY −3.2
10 Mar 3, 2026−5.16%
Before our storiesgroup −0.9%, did not move with it
10Mar 3, 2026−5.16%
Before our stories
−0.9% did not move with itMRK −1.3 · LLY −1.0 · JNJ −0.7 · ABBV −0.2
11 Mar 31, 2026+4.24%
Before our storiesgroup +1.9%, did not move with it
11Mar 31, 2026+4.24%
Before our stories
+1.9% did not move with itLLY +3.7 · ABBV +2.0 · MRK +1.9 · JNJ +0.8
12 Apr 17, 2026+4.78%
Before our storiesgroup +1.2%, did not move with it
12Apr 17, 2026+4.78%
Before our stories
+1.2% did not move with itMRK +3.1 · LLY +2.5 · JNJ −0.1 · ABBV −0.3
13 May 7, 2026+9.03%
Resultsgroup −1.1%, did not move with it
13May 7, 2026+9.03%
ResultsFirst close after the May 7 results filing
−1.1% did not move with itJNJ −0.9 · MRK −1.1 · ABBV −1.1 · LLY −1.2
14 May 15, 2026−4.52%
Before our storiesgroup −1.0%, did not move with it
14May 15, 2026−4.52%
Before our stories
−1.0% did not move with itMRK −1.8 · JNJ −1.8 · LLY −0.2 · ABBV −0.2
15 Jun 11, 2026+3.42%
Nothing on VTRSgroup +0.7%, did not move with it
15Jun 11, 2026+3.42%
Nothing on VTRSNo VTRS story, brief or results filing in our record that day
+0.7% did not move with itLLY +2.2 · MRK +1.4 · JNJ −0.1 · ABBV −0.1
16 Jul 2, 2026+3.21%
Nothing on VTRSgroup +3.5%, moved with VTRS
16Jul 2, 2026+3.21%
Nothing on VTRSNo VTRS story, brief or results filing in our record that day
+3.5% moved with VTRSABBV +4.0 · JNJ +3.6 · MRK +3.3 · LLY +1.9
17 Jul 16, 2026+3.90%
Nothing on VTRSgroup +2.2%, moved with VTRS
17Jul 16, 2026+3.90%
Nothing on VTRSNo VTRS story, brief or results filing in our record that day
+2.2% moved with VTRSABBV +4.2 · MRK +3.3 · JNJ +1.2 · LLY +1.1
18 Jul 21, 2026+3.53%
Nothing on VTRSgroup +1.3%, did not move with it
18Jul 21, 2026+3.53%
Nothing on VTRSNo VTRS story, brief or results filing in our record that day
+1.3% did not move with itLLY +2.5 · MRK +1.5 · ABBV +1.1 · JNJ +0.7
19 Jul 22, 2026−3.30%
Nothing on VTRSgroup −0.1%, did not move with it
19Jul 22, 2026−3.30%
Nothing on VTRSNo VTRS story, brief or results filing in our record that day
−0.1% did not move with itABBV −1.1 · LLY −1.1 · MRK +1.0 · JNJ +2.0
20 Aug 6, 2026−7.71%
Resultsgroup −0.1%, did not move with it
20Aug 6, 2026−7.71%
ResultsFirst close after the Aug 6 results filing
−0.1% did not move with itABBV −0.9 · JNJ −0.2 · MRK +0.0 · LLY +1.9
21 Aug 28, 2026−3.26%
Nothing on VTRSgroup −0.5%, did not move with it
21Aug 28, 2026−3.26%
Nothing on VTRSNo VTRS story, brief or results filing in our record that day
−0.5% did not move with itABBV −1.0 · MRK −0.8 · LLY −0.1 · JNJ +0.8
22 Oct 15, 2026+4.47%
Nothing on VTRSgroup −0.1%, did not move with it
22Oct 15, 2026+4.47%
Nothing on VTRSNo VTRS story, brief or results filing in our record that day
−0.1% did not move with itLLY +3.5 · ABBV −0.0 · JNJ −0.3 · MRK −1.5

A story on the same day is not a cause, and a group move is not proof either. Group: the median of LLY, JNJ, ABBV and MRK that day, the largest companies in VTRS’s SEC industry; “moved with VTRS” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). VTRS reports during the trading day, so day 1 is that day’s close. 3 of 4 times, day 6 ended on the same side as day 1.

Reported Nov 6, 2025

day 1−5.95%day 6+1.49%

Reported Feb 26, 2026

day 1−5.16%day 6−9.64%

Reported May 7, 2026

day 1+9.03%day 6+8.21%

Reported Aug 6, 2026

day 1−7.71%day 6−9.12%

Next report: expected early NovemberEstimated from the dates of its last four results filings. Not announced. Since the Aug 6 report: +5.69%. Four reports is a small sample.

Every report since 2022 →

Each line is VTRS’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$21.4B

Revenue$14.3B−3.00%

Net income$-3.5B

EPS, diluted$-3.00−466.00%

Gross margin35.1%

Operating margin-18.6%

Return on equity-23.9%

Debt / equity0.98

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$21.4B

Enterprise Value$34.5B

Income$-3.5B

Sales$14.3B

Book/sh$12.81

Cash/sh$1.17

Dividend TTM$0.48

Payout—

Employees—

IPO—

Quick Ratio0.82

Current Ratio1.38

Debt/Eq0.98

EPS (ttm)$-3.00

EPS this Y-466.0%

EPS past 3/5Y—

Sales past 3/5Y-4.2%

EPS Y/Y TTM-466.0%

Sales Y/Y TTM-3.0%

Shs Outstand1.15B

ROA-9.5%

ROE-23.9%

ROIC-9.2%

Gross Margin35.1%

Oper. Margin-18.6%

Profit Margin-24.6%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$17.9B

FY21

$16.3B

FY22

$15.4B

FY23

$14.7B

FY24

$14.3B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$17.9B	$16.3B	$15.4B	$14.7B	$14.3B
Gross Profit	$5.6B	$6.5B	$6.4B	$5.6B	$5.0B
Operating Income	$-34.0M	$1.6B	$766.2M	$10.1M	$-2.7B
Net Income	$-1.3B	$2.1B	$54.7M	$-634.2M	$-3.5B
Diluted EPS	$-1.05	$1.71	$0.05	$-0.53	$-3.00
Operating Cash Flow	$3.0B	$3.0B	$2.9B	$2.3B	$2.3B
Free Cash Flow	$2.6B	$2.6B	$2.5B	$2.0B	$1.9B

Same industry

VTRS against four drug peers, a year at 100

VTRS is up 83.4% in a year. All four did less: Merck (+72.1%), Eli Lilly (+56.6%), Johnson & Johnson (+32.3%) and AbbVie (+24.3%). Weekly closes, Oct 17, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.

Share this chart

VTRS +83.4%. Merck +72.1%, Eli Lilly +56.6%, Johnson & Johnson +32.3%, AbbVie +24.3%. Weekly closes, Oct 17, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in VTRS’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

LLY$1.18T JNJ$615.9B ABBV$504.4B MRK$360.1B ABT$181.5B PFE$168.6B VRTX$126.7B BMY$122.1B

Build basket with VTRS Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.